Short report

Prevalence of Hypertension in Older and Middle-aged Adults in China Open Access

--Estimates from Two National Longitudinal Surveys

Cuicui Xia

September 20, 2020

DOI:10.36316/gcatr.02.0034

ABSTRACT

Hypertension is a leading chronic risk for population health in China, especially for older and middle-aged adults. However, a representative estimate of hypertension prevalence lacks for general older populations. With datasets from the Chinese Longitudinal Healthy Longevity Study (CLHLS) and China Health and Retirement Longitudinal Study (CHARLS), two nationally representative longitudinal surveys, this report aims to provide some estimates of hypertension prevalence in older and middle-aged adults overall and by social and demographic variables. There had been a marked increase in hypertension prevalence from 41% to 52% among older adults over the past two decades. Older adults, who were females, with urban residence, high income, from eastern China, and engaged in non-agricultural work, were more likely to be hypertensive. About 30% of middle-aged people in China were suffering from hypertension. These findings are significant in identifying potentially vulnerable populations with hypertension, which may have implications for clinical intervention.

KEYWORDS:

Hypertension prevalence; Older adults; CLHLS; CHARLS

Copyright©2020 by the author(s).

Licensee Global Clinical and Translational Research. This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution License (CCBY4.0, https://creative-commons.org/licenses/by/4.0/),which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

How to cite this article:

Xia C. Prevalence of Hypertension in Older and Middle-aged Adults in China: Estimates from Two National Longitudinal Surveys. Glob Clin Transl Res. 2020; 2 (3): 78-84. DOI:10.36316/gcatr.02.0034

REFERENCES

1. World Health Organization. A Global Brief on Hypertension: Silent Killer and Global Public Health Crisis. Geneva, Switzerland: World Health Organi-zation,; 2013.

2. Alwan A, Armstrong T, Bettcher D, Branca F, Chisholm D, Ezzati M, et al. Global status report on noncom-municable diseases 2010. Alwan A, editor. Geneva, Switzerland: The World Health Organization; 2010.

3. National Center for Cardiovascular Diseases. Report on cardiovascular diseases in China 2017. Encyclopedia of China Publishing House. Beijing: China Publishing House; 2017. p. 6-32

4. Leigh JP, Du J. Hypertension and occupation among seniors. J Occup Environ Med. 2009;51(6):661-71.

5. Kaczmarek M, Stawińska-Witoszyńska B, Krzyżaniak A, Krzywińska-Wiewiorowska M, Siwińska A. Who is at higher risk of hypertension? Socioeconomic status differences in blood pressure among Polish adolescents: a population-based ADOPOLNOR study. Eur J Pediatr. 2015;174(11):1461-73.

6. Xia C, Li J. Socioeconomic status impact hyertensive risk and treatment among older adults in China. Glob Clin Transl Res. 2019;1(2):62-8.

7. Du J, Zhu G, Yue Y, Liu M, He Y. Blood pressure and hypertension prevalence among oldest-old in China for 16 year: based on CLHLS. BMC Geriatr. 2019;19(1):248.

8. Zeng Y. Introduction to the Chinese Longitudinal Healthy Longevity Survey (CLHLS). In: Zeng Y, Poston DL, Vlosky DA, Gu D, editors. Healthy Longevity in China: Demographic, Socioeconomic, and Psychological Dimensions. Dordrecht, Netherland: Springer; 2008.

9. Zeng Y, Vaupel J, Xiao Z, Zhang C, Liu Y. The Healthy Longevity Survey and the Active Life Expectancy of the Oldest Old in China. Population: An English Selection. 2001;13:95-116.

10. Zheng Z. Twenty year’s follow up on elder people’s health and quality of life. China Population and Development Studies. 2020;3:297-307.

11. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). International journal of epidemiology. 2014;43(1):61-8.

12. Zhao Y, Wang Y, Chen X, Meng Q, Tang H, Zhang T, et al. China Health and Retirement Report. Peking Universi-ty University, Beijing, China, 2019; http://charls.pku.edu.cn/Public/ashelf/public/uploads/document/public_documents/application/china-health-retirement-report.pdf

13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.

14. China Center for Economic Research Institute of Social Science Survey. China Health and Retirement Longitudinal Study Release Note. Peking University, Beijing, China, 2015;

http://charls.pku.edu.cn/Public/ashelf/public/uploads/document/2013-charls-wave2/application/CHARLS_Wave2_Release_Note.pdf

15. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62(1):18-26.

16. Neufcourt L, Deguen S, Bayat S, Zins M, Grimaud O. Gender differences in the association between socioeconomic status and hypertension in France: A cross-sectional analysis of the CONSTANCES cohort. PLoS One. 2020;15(4):e0231878.

17. Ba HO, Camara Y, Menta I, Sangare I, Sidibe N, Diall IB, et al. Hypertension and Associated Factors in Rural and Urban Areas Mali: Data from the STEP 2013 Survey. Int J Hypertens. 2018;2018:6959165.

18. Wu Y, Ye Z, Fang Y. Spatial analysis of the effects of PM2.5 on hypertension among the middle-aged and elderly people in China. Int J Environ Health Res. 2019:1-12.

19. Yu ES, Hong K, Chun BC. Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study. J Hypertens. 2020.

20. Kaplan MS, Huguet N, Feeny DH. Self-reported hypertension prevalence and income among older adults in Canada and the United States. Social science & Medicine. 2010;70(6):844-9.